On June 16, 2025, Tandem Diabetes Care (TNDM, Financial) garnered attention as Truist Securities initiated coverage on the company. Renowned analyst Richard Newitter spearheaded this initiation, providing investors with a new perspective on TNDM's market position.
Truist Securities assigned a "Hold" rating for Tandem Diabetes Care (TNDM, Financial), bringing focus to its current market standing. This new rating reflects the analyst's cautious yet attentive stance on the company's future prospects.
Additionally, Truist Securities has announced a price target of USD 24.00 for Tandem Diabetes Care (TNDM, Financial), suggesting a valuation approach based on existing market conditions and anticipated performance. This marks a fresh benchmark for investors evaluating TNDM's stock.
The announcement contributes to a broader understanding of Tandem Diabetes Care's (TNDM, Financial) financial outlook and strategic positioning, providing stakeholders with valuable insights into future stock movements.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 20 analysts, the average target price for Tandem Diabetes Care Inc (TNDM, Financial) is $35.85 with a high estimate of $75.00 and a low estimate of $18.00. The average target implies an upside of 72.69% from the current price of $20.76. More detailed estimate data can be found on the Tandem Diabetes Care Inc (TNDM) Forecast page.
Based on the consensus recommendation from 23 brokerage firms, Tandem Diabetes Care Inc's (TNDM, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Tandem Diabetes Care Inc (TNDM, Financial) in one year is $46.27, suggesting a upside of 122.88% from the current price of $20.76. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Tandem Diabetes Care Inc (TNDM) Summary page.
